Cubist Systematic Strategies LLC Acquires Shares of 31,260 American Renal Associates Holdings Inc (NYSE:ARA)

Share on StockTwits

Cubist Systematic Strategies LLC acquired a new stake in shares of American Renal Associates Holdings Inc (NYSE:ARA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 31,260 shares of the company’s stock, valued at approximately $233,000. Cubist Systematic Strategies LLC owned about 0.10% of American Renal Associates as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ARA. Private Asset Management Inc. bought a new position in shares of American Renal Associates in the 2nd quarter valued at about $115,000. Strs Ohio lifted its holdings in shares of American Renal Associates by 32.0% in the 2nd quarter. Strs Ohio now owns 79,200 shares of the company’s stock valued at $589,000 after acquiring an additional 19,200 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of American Renal Associates in the 2nd quarter valued at about $121,000. Adams Diversified Equity Fund Inc. lifted its holdings in shares of American Renal Associates by 24.7% in the 2nd quarter. Adams Diversified Equity Fund Inc. now owns 22,239 shares of the company’s stock valued at $165,000 after acquiring an additional 4,400 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of American Renal Associates in the 2nd quarter valued at about $416,000. 86.23% of the stock is owned by institutional investors and hedge funds.

Shares of NYSE:ARA opened at $6.26 on Tuesday. The company has a current ratio of 1.03, a quick ratio of 1.00 and a debt-to-equity ratio of 7.82. American Renal Associates Holdings Inc has a 12 month low of $5.48 and a 12 month high of $20.97. The company has a 50-day moving average price of $7.25 and a 200 day moving average price of $6.92. The company has a market cap of $200.90 million, a price-to-earnings ratio of 8.76 and a beta of 2.01.

A number of brokerages recently commented on ARA. SunTrust Banks increased their price target on shares of American Renal Associates from $7.00 to $12.00 and gave the company a “hold” rating in a report on Tuesday, September 10th. ValuEngine raised shares of American Renal Associates from a “hold” rating to a “buy” rating in a report on Wednesday, October 2nd. Seven equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $11.25.

American Renal Associates Profile

American Renal Associates Holdings, Inc operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease.

Read More: How interest rates affect municipal bond prices

Institutional Ownership by Quarter for American Renal Associates (NYSE:ARA)

Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.